The fact that a commercial team has been built shows me the management team's confidence in the future of some of these trials.
However, earlier in the presentation, it's been pointed out that there are strategies for building partnerships for the sake of rem-L commercialisation in C-19 ARDS.
Sounds very promising!
DYOR, GLTAH
Ann: MSB Annual Financial Results and Operational Progress, page-17
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
0.280(11.0%) |
Mkt cap ! $3.245B | |||
| Open | High | Low | Value | Volume |
| $2.74 | $2.84 | $2.68 | $48.39M | 17.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 212409 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 9068 | 2 |
View Market Depth
| Last trade - 16.10pm 27/12/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
